Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Quality assurance].
Flentje M, Hoffmann H, Huber RM. Flentje M, et al. Among authors: huber rm. Onkologie. 2012;35 Suppl 3:14-6. doi: 10.1159/000338990. Epub 2012 May 15. Onkologie. 2012. PMID: 22678020 Free article. German. No abstract available.
[Tumor conference II].
Tufman A, Schumann C, Huber RM, Eberhardt W, Flentje M, Haug A, Junker K, Pfluger T, Winter H. Tufman A, et al. Among authors: huber rm. Onkologie. 2013;36 Suppl 6:14-6. doi: 10.1159/000353715. Epub 2013 Aug 12. Onkologie. 2013. PMID: 24162625 Free article. German. No abstract available.
[Concept of quality assurance in the management of lung carcinoma].
Blankenburg T, Flentje M, Friedel G, Huber RM, Tesch H. Blankenburg T, et al. Among authors: huber rm. Onkologie. 2006 Sep;29 Suppl 2:20-4. doi: 10.1159/000094951. Epub 2006 Sep 6. Onkologie. 2006. PMID: 16974124 Review. German. No abstract available.
New developments in locally advanced nonsmall cell lung cancer.
Huber RM, Kauffmann-Guerrero D, Hoffmann H, Flentje M. Huber RM, et al. Eur Respir Rev. 2021 May 5;30(160):200227. doi: 10.1183/16000617.0227-2020. Print 2021 Jun 30. Eur Respir Rev. 2021. PMID: 33952600 Free PMC article.
Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany.
Hörsch D, Schmid KW, Anlauf M, Darwiche K, Denecke T, Baum RP, Spitzweg C, Grohé C, Presselt N, Stremmel C, Heigener DF, Serke M, Kegel T, Pavel M, Waller CF, Deppermann KM, Arnold R, Huber RM, Weber MM, Hoffmann H. Hörsch D, et al. Among authors: huber rm. Oncol Res Treat. 2014;37(5):266-76. doi: 10.1159/000362430. Epub 2014 Apr 14. Oncol Res Treat. 2014. PMID: 24853787 Review.
Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
Huber RM, Flentje M, Schmidt M, Pöllinger B, Gosse H, Willner J, Ulm K; Bronchial Carcinoma Therapy Group. Huber RM, et al. J Clin Oncol. 2006 Sep 20;24(27):4397-404. doi: 10.1200/JCO.2005.05.4163. J Clin Oncol. 2006. PMID: 16983107 Clinical Trial.
GILT--A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer.
Flentje M, Huber RM, Engel-Riedel W, Andreas S, Kollmeier J, Staar S, Dickgreber N, Vaissiere N, De Almeida C, Edlich B, Fietkau R. Flentje M, et al. Among authors: huber rm. Strahlenther Onkol. 2016 Apr;192(4):216-22. doi: 10.1007/s00066-016-0941-8. Epub 2016 Jan 25. Strahlenther Onkol. 2016. PMID: 26809652 Clinical Trial.
277 results